IVICO
0808.680.387 · rovalta.com · 22/09/2026
IVICO
Overview
What does IVICO do?
IVICO is a Private company with limited liability incorporated in 2008. Its main activity is: Legal activities. Its registered office is in Woluwe-Saint-Pierre.
1150 Woluwe-Saint-Pierre · BruxellesSee on map
Trend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | 238,7 k € | +3.2% | 231,4 k € | -17.2% | 279,5 k € | +109% | 133,5 k € | -9.1% | 146,9 k € | +30.9% | 112,2 k € | -3.9% | 116,8 k € | -39.6% | 193,2 k € | +92.3% | 100,5 k € | -30.8% | 145,1 k € | +65.2% | 87,9 k € | +15.2% | 76,3 k € | -21.2% | 96,8 k € | -0.4% | 97,2 k € | +373% | -35,6 k € | -156% | 64 k € |
| EBITDA | 232,4 k € | +3.7% | 224 k € | -14.8% | 262,9 k € | +107% | 126,8 k € | +118% | 58,3 k € | -45.5% | 107 k € | -5.9% | 113,7 k € | -37.0% | 180,3 k € | +80.7% | 99,8 k € | -30.2% | 143 k € | +63.5% | 87,4 k € | +15.2% | 75,9 k € | -19.4% | 94,2 k € | -1.1% | 95,3 k € | +363% | -36,2 k € | -159% | 61 k € |
| Operating result | 38,3 k € | -68.0% | 119,8 k € | +78.9% | 67 k € | +305% | 16,5 k € | +134% | -48,3 k € | -220% | 40,3 k € | -27.7% | 55,7 k € | -57.0% | 129,6 k € | +223% | -105,3 k € | -210% | 96 k € | +141% | 39,9 k € | -29.8% | 56,8 k € | -21.8% | 72,7 k € | -12.4% | 83 k € | +272% | -48,2 k € | -408% | 15,6 k € |
| Net result | 15,9 k € | -83.4% | 95,5 k € | +464% | 16,9 k € | +269% | -10 k € | +86.0% | -71,6 k € | -544% | 16,1 k € | -53.7% | 34,9 k € | -65.3% | 100,5 k € | +190% | -112 k € | -236% | 82,2 k € | +374% | 17,4 k € | -61.2% | 44,7 k € | -19.1% | 55,3 k € | -21.3% | 70,2 k € | +210% | -63,8 k € | -2082% | -2,9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | 111,2 k € | +15.1% | 96,6 k € | +17.2% | 82,4 k € | +23.4% | 66,8 k € | -14.5% | 78,1 k € | -48.3% | 151 k € | +12.0% | 134,9 k € | +50.7% | 89,5 k € | +310% | -42,6 k € | -161% | 69,4 k € | +21.4% | 57,2 k € | +43.6% | 39,8 k € | +58.6% | 25,1 k € | +330% | 5,8 k € | +111% | -54,3 k € | -674% | 9,5 k € |
| Total assets | 2 M € | +2.1% | 1,9 M € | -2.3% | 2 M € | -2.3% | 2 M € | -1.2% | 2 M € | +64.4% | 1,2 M € | -8.0% | 1,3 M € | -2.3% | 1,4 M € | -9.3% | 1,5 M € | +210% | 491,1 k € | +14.4% | 429,2 k € | +44.4% | 297,1 k € | -14.4% | 347,1 k € | +17.3% | 295,9 k € | +6.3% | 278,5 k € | +5.3% | 264,4 k € |
| Cash | 51,2 k € | -39.5% | 84,7 k € | +63.8% | 51,7 k € | +743% | 6,1 k € | -37.9% | 9,9 k € | -39.0% | 16,2 k € | -77.8% | 73 k € | +377% | 15,3 k € | +33.6% | 11,5 k € | +3978% | 281 € | -99.2% | 35,4 k € | +2131% | 1,6 k € | -95.0% | 32,1 k € | +3.8% | 30,9 k € | -22.4% | 39,8 k € | +22149% | 179 € |
| Debts | 1,7 M € | +1.6% | 1,7 M € | -2.9% | 1,7 M € | -3.7% | 1,8 M € | -0.6% | 1,8 M € | +92.9% | 945,9 k € | -11.6% | 1,1 M € | -16.2% | 1,3 M € | -18.1% | 1,6 M € | +270% | 420,8 k € | +13.4% | 371 k € | +44.7% | 256,3 k € | -19.8% | 319,7 k € | +10.7% | 288,8 k € | -13.2% | 332,8 k € | +30.6% | 254,9 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Aurélie Meledina, Avocat● Active | 0805.333.194 |
CONGRESS PHARMA● Active | 0743.735.919 |
Laurent MASSON, Avocat● Active | 0859.631.321 |
OLIVIER WILLEZ AVOCAT SPRL● Active | 0480.216.613 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 21 months | 12 months | 12 months | 12 months |
| Filing date | 28/08/2026 | 09/10/2025 | 31/08/2024 | 31/10/2022 | 06/12/2021 | 08/12/2020 |
| General meeting | 28/08/2026 | 29/09/2025 | 16/06/2024 | 15/09/2022 | 15/09/2021 | 15/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 28/08/2026 | 28/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 29/09/2025 | 09/10/2025 | Dutch | |
| Abridged model | 31/12/2023 | 16/06/2024 | 31/08/2024 | Dutch | |
| Abridged model | 31/03/2022 | 15/09/2022 | 31/10/2022 | Dutch | |
| Abridged model | 31/03/2021 | 15/09/2021 | 06/12/2021 | Dutch | |
| Abridged model | 31/03/2020 | 15/09/2020 | 08/12/2020 | Dutch | |
| Abridged model | 31/03/2019 | 16/09/2019 | 23/10/2019 | Dutch | |
| Abridged model | 31/03/2018 | 15/09/2018 | 16/11/2018 | Dutch | |
| Abridged model | 31/03/2017 | 15/09/2017 | 30/11/2017 | Dutch | |
| Abridged model | 31/03/2016 | 15/09/2016 | 23/09/2016 | Dutch | |
| Abridged model | 31/03/2015 | 15/09/2015 | 30/11/2015 | Dutch | |
| Abridged model | 31/03/2014 | 15/09/2014 | 17/10/2014 | Dutch | |
| Abridged model | 31/03/2013 | 15/09/2013 | 17/10/2013 | Dutch | |
| Abridged model | 31/03/2012 | 15/09/2012 | 12/11/2012 | Dutch | |
| Abridged model | 31/03/2011 | 15/09/2011 | 29/11/2011 | Dutch | |
| Abridged model | 31/03/2010 | 15/09/2010 | 15/11/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Restructuring22/08/2022CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring25/02/2022RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring10/01/2019RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring20/11/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Registered office12/07/2017MAATSCHAPPELIJKE ZETEL
- Other26/08/2016DOEL
- Mandates03/06/2010BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Mandates09/09/2009ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202515,9 k €↓
- 2024Annual accounts 202495,5 k €↑
- 2024Name changeIVICO
- 2023Annual accounts 202316,9 k €↑
- 2022Annual accounts 2022-10 k €↑
- 2022Name changeIV TRADE & CONSULTING BV
- 2021Annual accounts 2021-71,6 k €↓
- 2020Annual accounts 202016,1 k €↓
- 2019Annual accounts 201934,9 k €↓
- 2018Annual accounts 2018100,5 k €↑
- 2017Annual accounts 2017-112 k €↓
- 2016Annual accounts 201682,2 k €↑
- 2015Annual accounts 201517,4 k €↓
- 2014Annual accounts 201444,7 k €↓
- 2013Annual accounts 201355,3 k €↓
- 2012Annual accounts 201270,2 k €↑
- 2011Annual accounts 2011-63,8 k €↓
- 2010Annual accounts 2010-2,9 k €
- 24/12/2008IncorporationPrivate company with limited liability